Dr. Sakaguchi, M.D., Ph.D. Professor, Osaka University, discovered regulatory T (Treg) cells, which compose of five percent of T cells and are specialized for immuno-supression. He has being studying the molecular basis of the development of naturally occurring Treg cells, and also human Treg cells, in particular, analyzing anti-tumor immune responses against adult T-cell leukemia, shedding new light on cancer immunotherapy. He was elected as a member of National Academy of Sciences in 2012 and was also selected as one of the “Highly Cited Researchers” by Thomson Reuters CO, USA.
EdX
Dive into the fascinating world of immunology with 'The Immune System: New Developments in Research - Part 1'. This course offers a blend of foundational principles and advanced topics from groundbreaking research. Learn about cancer immunotherapy, novel vaccine development, and other innovative approaches that are shaping the future of healthcare.